Genomic Vision (CHIX:GVP) Total Liabilities : €6.73 Mil (As of Jun. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Genomic Vision Total Liabilities?

Genomic Vision's Total Liabilities for the quarter that ended in Jun. 2023 was €6.73 Mil.

Genomic Vision's quarterly Total Liabilities increased from Jun. 2022 (€4.29 Mil) to Dec. 2022 (€6.28 Mil) and increased from Dec. 2022 (€6.28 Mil) to Jun. 2023 (€6.73 Mil).

Genomic Vision's annual Total Liabilities declined from Dec. 2020 (€4.18 Mil) to Dec. 2021 (€3.70 Mil) but then increased from Dec. 2021 (€3.70 Mil) to Dec. 2022 (€6.28 Mil).

Genomic Vision Total Liabilities Historical Data

The historical data trend for Genomic Vision's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Vision Total Liabilities Chart

Genomic Vision Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

4.54

2.38

4.18

3.70

6.28

Genomic Vision Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Total Liabilities	Get a 7-Day Free Trial															4.25	3.70	4.29	6.28	6.73

Genomic Vision Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genomic Vision's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3.912	+	(2.125	+	-0.00099999999999978
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.241)
	=	6.28

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	4.989	-	-1.288
	=	6.28

Genomic Vision's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5.702	+	(0.785	+	-2.2204460492503E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.241)
	=	6.73

Total Liabilities	=	Total Assets (Q: Jun. 2023 )	-	Total Equity (Q: Jun. 2023 )
	=	3.957	-	-2.771
	=	6.73

Genomic Vision Total Liabilities Related Terms

Thank you for viewing the detailed overview of Genomic Vision's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomic Vision (CHIX:GVP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomic Vision SA (CHIX:GVp) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

80-84 rue des Meuniers, Green Square, Batiment E, Bagneux, FRA, 92220

Website

http://www.genomicvision.com

Genomic Vision SA is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics.